Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy: a prospective, randomized, double-blind clinical trial (RECIR) - RECIR

FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE0 个研究点目标入组 34 人开始时间: 2021年5月24日最近更新: 2023年9月11日

适应症

试验速览

暂无简介。

•patient’s age =65years, robot-assisted laparoscopic radical prostatectomy (RALP).
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 34

•Inability to obtain written informed consent, history of significant liver or renal diseases, chronic or acute alcoholism, known or suspected neuromuscular disorders, a family history of malignant hyperthermia, BMI =30 Kg/m2, known allergy or hypersensitivity to drugs used, or planned admission to postoperative intensive care unit. Patients showing moderate neuromuscular block (TOF count=1-3) will be excluded from the study. (pag 5 protocol)

发起方

FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE